LAVAL, Québec–(BUSINESS WIRE)–#Altasciences—The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Altasciences’ clinical site in Los Angeles, California, based on results of a recent on-site inspection.
Altasciences was advised of this national recognition and congratulated for the excellence of the services being provided. Altasciences’ Los Angeles site is one of more than 8,000 CAP-accredited facilities worldwide.
“This prestigious accreditation is a testament to the high-quality work and oversight by Altasciences’ dedicated and passionate team in Los Angeles. We are pleased to give our clients the peace of mind that comes with working with a CAP-accredited biorepository, and are proud to have a seal of approval that reflects the quality of our work,” stated Dr. David Nguyen, General Manager and Medical Director at Altasciences’ Los Angeles site.
The CAP, first in the industry to offer an accreditation program for biorepositories, based the Biorepository Accreditation Program on the principles of its Laboratory Accreditation Program. The U.S. federal government recognizes the CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal to, or more stringent than, the government’s own inspection program. Currently, there is no federal mandate for biorepository accreditation.
The CAP Biorepository Accreditation Program, a three-year accreditation cycle, includes on-site inspection, desk review, and optional education modules and gap assessment. As part of the on-site inspection, the CAP uses accreditation checklists to provide a comprehensive, up-to-date blueprint of quality practices to assist biorepositories in improving their operations and ensure quality. Further, a desk review offers a remote review of a biorepository’s quality management plan, certain procedures, and select quality and process statistics. The program is designed to ensure the highest standard of patient care.
Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster.
About the College of American Pathologists
As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing program, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the CAP ANNUAL REPORT at cap.org.
+1 514 601-9763